Skip to content

Retrospective study of treatment outcomes and safety of preoperative chemotherapy for resectable esophageal cancer

Retrospective study of treatment outcomes and safety of preoperative chemotherapy for resectable esophageal cancer - Retrospective study of treatment outcomes and safety of preoperative chemotherapy for resectable esophageal cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000059956
Enrollment
100
Registered
2025-12-10
Start date
2025-11-26
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal cancer

Interventions

None listed

Sponsors

University of toyama
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: resectable esophageal cancer patient

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

MeasureTime frame
disease free survival

Secondary

MeasureTime frame
response rate, overall survival, frequency of adverse event

Countries

Japan

Contacts

Public ContactKohei Nagata

University of toyama Third department of ineternal medicine

nagatako@med-u.toyama.ac.jp076-434-7301

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026